Most Active InvestorsFind investorsPricing
Start for free
Start for free
Tachyon Ventures logo

Tachyon Ventures

North America, California, United States, Los Angeles

Description

Tachyon Ventures is invests in early-stage life sciences ventures at the forefront of medicine, biotech and bioengineering.

Investor Profile

Tachyon Ventures has backed more than 19 startups, with 3 new investments in the last 12 months alone. The firm has led 2 rounds, about 11% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Singapore.
  • Strong thematic focus on Biotechnology, Therapeutics, Life Science.

Stage Focus

  • Series A (32%)
  • Seed (26%)
  • Series B (16%)
  • Series Unknown (11%)
  • Series C (5%)
  • Series D (5%)
  • Angel (5%)

Country Focus

  • United States (95%)
  • Singapore (5%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Life Science
  • Genetics
  • Health Care
  • Health Diagnostics
  • Alternative Medicine
  • Pharmaceutical
  • Medical
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tachyon Ventures frequently co-invest with?

NFX
NFX
North America, California, United States, San Francisco
Co-Investments: 3
Amgen Ventures
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Mayfield Fund
Mayfield Fund
North America, California, United States, Menlo Park
Co-Investments: 3
Plum Alley
Plum Alley
North America, New York, United States, New York
Co-Investments: 3
Thiel Capital
Thiel Capital
North America, California, United States, Los Angeles
Co-Investments: 2
aMoon Fund
aMoon Fund
Asia, HaMerkaz, Israel, Ra'anana
Co-Investments: 2
Viva Biotech
Viva Biotech
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Bioverge
Bioverge
North America, California, United States, San Francisco
Co-Investments: 2
Eli Lilly
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 3
Khosla Ventures
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

Which angels does Tachyon Ventures often collaborate with?

JH
Jeff Huber
North America, Nevada, United States, Incline Village
Shared Deals: 1
PT
Peter Thiel
North America, California, United States, San Francisco
Shared Deals: 1
AI
Andrew Izyumov
Europe, Cyprus
Shared Deals: 1
TC
Tim Cook
North America, California, United States, Palo Alto
Shared Deals: 1
BH
Bradley Horowitz
North America, California, United States, Palo Alto
Shared Deals: 1
BB
Brook Byers
North America, California, United States, San Francisco
Shared Deals: 1
JM
Jonathan Milner
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Tachyon Ventures?

Stylus Medicine

Cambridge, Massachusetts, United States

Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.

BiotechnologyEmergency MedicineSaaS
Series AMay 12, 2025
Amount Raised: $85,000,000
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
EnClear Therapies

Cambridge, Massachusetts, United States

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

BiotechnologyTherapeutics
Series UnknownSep 3, 2024
Altay Therapeutics

San Francisco, California, United States

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.

BiotechnologyHealth CareLife ScienceTherapeutics
SeedMay 23, 2022
Mammoth Biosciences

San Francisco, California, United States

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

BiotechnologyGeneticsHealth DiagnosticsLife Science
Series DSep 9, 2021
Amount Raised: $150,000,000
Chameleon Biosciences

San Anselmo, California, United States

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

BiotechnologyGeneticsTherapeutics
SeedMar 25, 2021
Amount Raised: $11,100,000
Scipher Medicine

Waltham, Massachusetts, United States

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.

Alternative MedicineBiotechnologyGeneticsHealth CareHealth Diagnostics
Series CMar 24, 2021
Amount Raised: $82,000,000
DTx Pharma

San Diego, California, United States

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

BiotechnologyPharmaceuticalTherapeutics
Series BMar 1, 2021
Amount Raised: $100,000,000
Totient

Cambridge, Massachusetts, United States

Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures.

Artificial Intelligence (AI)BiotechnologyLife ScienceMachine Learning
SeedSep 10, 2020
Amount Raised: $10,000,000
TARA Biosystems

New York, New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

BiotechnologyMedical
Series AJun 23, 2020
Amount Raised: $10,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator